AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
RET PTC ONCOGENE ACTIVATION DEFINES A SUBSET OF PAPILLARY THYROID CARCINOMAS LACKING EVIDENCE OF PROGRESSION TO POORLY DIFFERENTIATED OR UNDIFFERENTIATED TUMOR PHENOTYPES/
Authors: TALLINI G SANTORO M HELIE M CARLOMAGNO F SALVATORE G CHIAPPETTA G CARCANGIU ML FUSCO A
Citation: G. Tallini et al., RET PTC ONCOGENE ACTIVATION DEFINES A SUBSET OF PAPILLARY THYROID CARCINOMAS LACKING EVIDENCE OF PROGRESSION TO POORLY DIFFERENTIATED OR UNDIFFERENTIATED TUMOR PHENOTYPES/, Clinical cancer research, 4(2), 1998, pp. 287-294
RET PTC ONCOGENE ACTIVATION DEFINES A SUBSET OF PAPILLARY THYROID CARCINOMAS LACKING EVIDENCE OF PROGRESSION TO POORLY DIFFERENTIATED OR UNDIFFERENTIATED TUMOR PHENOTYPES/
Authors: TALLINI G SANTORO M HELIE M CARLOMAGNO F SALVATORE G CHIAPPETTA G CARCANGIU ML FUSCO A
Citation: G. Tallini et al., RET PTC ONCOGENE ACTIVATION DEFINES A SUBSET OF PAPILLARY THYROID CARCINOMAS LACKING EVIDENCE OF PROGRESSION TO POORLY DIFFERENTIATED OR UNDIFFERENTIATED TUMOR PHENOTYPES/, Clinical cancer research, 4(2), 1998, pp. 287-294
SEROUS CARCINOMA OF THE UTERUS TREATED WITH CISPLATIN, DOXORUBICIN AND ETOPOSIDE
Authors: CHAMBERS JT RUTHERFORD TJ BAKER L KOHORN EI SCHWARTZ PE CARCANGIU ML CHAMBERS SK
Citation: Jt. Chambers et al., SEROUS CARCINOMA OF THE UTERUS TREATED WITH CISPLATIN, DOXORUBICIN AND ETOPOSIDE, International journal of gynecological cancer, 8(3), 1998, pp. 193-196
UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN EPITHELIAL OVARIAN-CANCER - APOOR PROGNOSTIC FACTOR, ASSOCIATED WITH ADVANCED-STAGE
Authors: CHAMBERS SK IVINS CM CARCANGIU ML
Citation: Sk. Chambers et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN EPITHELIAL OVARIAN-CANCER - APOOR PROGNOSTIC FACTOR, ASSOCIATED WITH ADVANCED-STAGE, International journal of gynecological cancer, 8(3), 1998, pp. 242-250
POORLY DIFFERENTIATED TROPHOBLASTIC TUMOR, SIMULATING SQUAMOUS-CELL CARCINOMA
Authors: PARKASH V TAN LK CARCANGIU ML
Citation: V. Parkash et al., POORLY DIFFERENTIATED TROPHOBLASTIC TUMOR, SIMULATING SQUAMOUS-CELL CARCINOMA, Modern pathology, 11(1), 1998, pp. 111-111
PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS AN INDEPENDENT POOR PROGNOSTIC FACTOR FOR SURVIVAL IN ADVANCED-STAGE EPITHELIAL OVARIAN-CANCER PATIENTS
Authors: CHAMBERS SK IVINS CM CARCANGIU ML
Citation: Sk. Chambers et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS AN INDEPENDENT POOR PROGNOSTIC FACTOR FOR SURVIVAL IN ADVANCED-STAGE EPITHELIAL OVARIAN-CANCER PATIENTS, International journal of cancer, 79(5), 1998, pp. 449-454
DOES PELVIC MAGNETIC-RESONANCE-IMAGING DIFFERENTIATE AMONG THE HISTOLOGIC SUBTYPES OF UTERINE LEIOMYOMATA
Authors: SCHWARTZ LB ZAWIN M CARCANGIU ML LANGE R MCCARTHY S
Citation: Lb. Schwartz et al., DOES PELVIC MAGNETIC-RESONANCE-IMAGING DIFFERENTIATE AMONG THE HISTOLOGIC SUBTYPES OF UTERINE LEIOMYOMATA, Fertility and sterility, 70(3), 1998, pp. 580-587
CA-125 MAY NOT REFLECT DISEASE STATUS IN PATIENTS WITH UTERINE SEROUSCARCINOMA
Authors: PRICE FV CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE CHAMBERS JT
Citation: Fv. Price et al., CA-125 MAY NOT REFLECT DISEASE STATUS IN PATIENTS WITH UTERINE SEROUSCARCINOMA, Cancer, 82(9), 1998, pp. 1720-1725
OVEREXPRESSION OF EPITHELIAL MACROPHAGE-COLONY-STIMULATING FACTOR (CSF-1) AND CSF-1 RECEPTOR - A POOR PROGNOSTIC FACTOR IN EPITHELIAL OVARIAN-CANCER, CONTRASTED WITH A PROTECTIVE EFFECT OF STROMAL CSF-1
Authors: CHAMBERS SK KACINSKI BM IVINS CM CARCANGIU ML
Citation: Sk. Chambers et al., OVEREXPRESSION OF EPITHELIAL MACROPHAGE-COLONY-STIMULATING FACTOR (CSF-1) AND CSF-1 RECEPTOR - A POOR PROGNOSTIC FACTOR IN EPITHELIAL OVARIAN-CANCER, CONTRASTED WITH A PROTECTIVE EFFECT OF STROMAL CSF-1, Clinical cancer research, 3(6), 1997, pp. 999-1007
WANTED - MORE EVIDENCE ON WHETHER ESTROGEN REPLACEMENT CAUSES CANCER
Authors: NAFTOLIN F RUTHERFORD TJ CHAMBERS JT CARCANGIU ML
Citation: F. Naftolin et al., WANTED - MORE EVIDENCE ON WHETHER ESTROGEN REPLACEMENT CAUSES CANCER, Journal of the Society for Gynecologic Investigation, 4(2), 1997, pp. 57-57
MINIMALLY INVASIVE FOLLICULAR CARCINOMA
Authors: CARCANGIU ML
Citation: Ml. Carcangiu, MINIMALLY INVASIVE FOLLICULAR CARCINOMA, Endocrine pathology, 8(3), 1997, pp. 231-234
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA WITH PSAMMOMA BODIES
Authors: PARKASH V CARCANGIU ML
Citation: V. Parkash et Ml. Carcangiu, ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA WITH PSAMMOMA BODIES, The American journal of surgical pathology, 21(4), 1997, pp. 399-406
STAGE IA UTERINE SEROUS CARCINOMA - A STUDY OF 13 CASES
Authors: CARCANGIU ML TAN LK CHAMBERS JT
Citation: Ml. Carcangiu et al., STAGE IA UTERINE SEROUS CARCINOMA - A STUDY OF 13 CASES, The American journal of surgical pathology, 21(12), 1997, pp. 1507-1514
ABNORMAL INTRACELLULAR AND EXTRACELLULAR DISTRIBUTION OF BASEMENT-MEMBRANE MATERIAL IN PAPILLARY CARCINOMA AND HYALINIZING TRABECULAR TUMORS OF THE THYROID - IMPLICATION FOR DEREGULATION OF SECRETORY PATHWAYS
Authors: LI MM CARCANGIU ML ROSAI J
Citation: Mm. Li et al., ABNORMAL INTRACELLULAR AND EXTRACELLULAR DISTRIBUTION OF BASEMENT-MEMBRANE MATERIAL IN PAPILLARY CARCINOMA AND HYALINIZING TRABECULAR TUMORS OF THE THYROID - IMPLICATION FOR DEREGULATION OF SECRETORY PATHWAYS, Human pathology, 28(12), 1997, pp. 1366-1372
EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN EPITHELIAL OVARIAN-CANCER - A FAVORABLE PROGNOSTIC FACTOR-RELATED TO THE ACTIONS OF CSF-1
Authors: CHAMBERS SK IVINS CM CARCANGIU ML
Citation: Sk. Chambers et al., EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN EPITHELIAL OVARIAN-CANCER - A FAVORABLE PROGNOSTIC FACTOR-RELATED TO THE ACTIONS OF CSF-1, International journal of cancer, 74(6), 1997, pp. 571-575
EPITHELIAL EXPRESSION AND CHROMOSOMAL LOCATION OF HUMAN TLE GENES - IMPLICATIONS FOR NOTCH SIGNALING AND NEOPLASIA
Authors: LIU YL DEHNI G PURCELL KJ SOKOLOW J CARCANGIU ML ARTAVANISTSAKONAS S STIFANI S
Citation: Yl. Liu et al., EPITHELIAL EXPRESSION AND CHROMOSOMAL LOCATION OF HUMAN TLE GENES - IMPLICATIONS FOR NOTCH SIGNALING AND NEOPLASIA, Genomics, 31(1), 1996, pp. 58-64
COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, CISPLATIN, AND DOXORUBICIN IN MIXED MULLERIAN TUMORS OF THE ADNEXA
Authors: CASS I RESNIK E CHAMBERS JT CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE
Citation: I. Cass et al., COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, CISPLATIN, AND DOXORUBICIN IN MIXED MULLERIAN TUMORS OF THE ADNEXA, Gynecologic oncology, 61(3), 1996, pp. 309-314
UTERINE PAPILLARY SEROUS CARCINOMA TREATED WITH INTRAPERITONEAL CISPLATIN AND INTRAVENOUS DOXORUBICIN AND CYCLOPHOSPHAMIDE
Authors: CHAMBERS JT CHAMBERS SK KOHORN EI CARCANGIU ML SCHWARTZ PE
Citation: Jt. Chambers et al., UTERINE PAPILLARY SEROUS CARCINOMA TREATED WITH INTRAPERITONEAL CISPLATIN AND INTRAVENOUS DOXORUBICIN AND CYCLOPHOSPHAMIDE, Gynecologic oncology, 60(3), 1996, pp. 438-442
ABNORMAL ACCUMULATION OF BASEMENT-MEMBRANE MATERIAL IN THE NUCLEAR PSEUDOINCLUSIONS OF PAPILLARY CARCINOMA AND HYALINIZING TRABECULAR TUMORS OF THE THYROID
Authors: LI M CARCANGIU ML ROSAI J
Citation: M. Li et al., ABNORMAL ACCUMULATION OF BASEMENT-MEMBRANE MATERIAL IN THE NUCLEAR PSEUDOINCLUSIONS OF PAPILLARY CARCINOMA AND HYALINIZING TRABECULAR TUMORS OF THE THYROID, Laboratory investigation, 74(1), 1996, pp. 275-275
RET EXPRESSION IN THYROID NEOPLASIA - A STUDY OF 235 CASES
Authors: TALLINI G CARCANGIU ML HELIE M SANTORO M FUSCO A
Citation: G. Tallini et al., RET EXPRESSION IN THYROID NEOPLASIA - A STUDY OF 235 CASES, Laboratory investigation, 74(1), 1996, pp. 286-286
NONINVASIVE UTERINE PAPILLARY SEROUS CARCINOMA (UPSC) - A STUDY OF 11CASES
Authors: CARCANGIU ML CHAMBERS J
Citation: Ml. Carcangiu et J. Chambers, NONINVASIVE UTERINE PAPILLARY SEROUS CARCINOMA (UPSC) - A STUDY OF 11CASES, Laboratory investigation, 74(1), 1996, pp. 505-505
ENDOMETRIOID ENDOMETRIAL CARCINOMA WITH PSAMMOMA BODIES
Authors: PARKASH V CARCANGIU ML
Citation: V. Parkash et Ml. Carcangiu, ENDOMETRIOID ENDOMETRIAL CARCINOMA WITH PSAMMOMA BODIES, Laboratory investigation, 74(1), 1996, pp. 554-554
EFFECTS OF CHEMOTHERAPY ON NEOPLASTIC AND NONNEOPLASTIC UTERINE CERVIX
Authors: PARKASH V CHAMBERS S CARCANGIU ML
Citation: V. Parkash et al., EFFECTS OF CHEMOTHERAPY ON NEOPLASTIC AND NONNEOPLASTIC UTERINE CERVIX, Laboratory investigation, 74(1), 1996, pp. 555-555
MALIGNANT UTERINE SMOOTH-MUSCLE TUMORS - ROLE OF ETOPOSIDE, CISPLATIN, AND DOXORUBICIN (EPA) CHEMOTHERAPY
Authors: RESNIK E CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE CHAMBERS JT
Citation: E. Resnik et al., MALIGNANT UTERINE SMOOTH-MUSCLE TUMORS - ROLE OF ETOPOSIDE, CISPLATIN, AND DOXORUBICIN (EPA) CHEMOTHERAPY, Journal of surgical oncology, 63(3), 1996, pp. 145-147
TRANSFORMATION OF OVARIAN DYSGERMINOMA TO YOLK-SAC TUMOR - EVIDENCE FOR A HISTOGENETIC CONTINUUM
Authors: PARKASH V CARCANGIU ML
Citation: V. Parkash et Ml. Carcangiu, TRANSFORMATION OF OVARIAN DYSGERMINOMA TO YOLK-SAC TUMOR - EVIDENCE FOR A HISTOGENETIC CONTINUUM, Modern pathology, 8(8), 1995, pp. 881-887
Risultati: 1-25 | 26-44